| Hans-Günter Meyer-Thompson | Buprenorphin
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S.
Neuropsychiatr Dis Treat. 2019 Apr 4;15:795-808. doi: 10.2147/NDT.S199245.